Rx (Prescription Medicine)
USD $ 120.00
Eleftha 150mg 注射剂是一种靶向疗法，用于治疗特定类型的癌症。其活性成分被认为是一种专门设计的分子，可干扰癌细胞的生长和扩散。该药物通过抑制癌细胞生存与增殖所依赖的关键通路，从而减缓或停止肿瘤进展。Eleftha 150mg 注射剂适用于特定的肿瘤学适应症，其使用应由合格的肿瘤科医生指导。剂量和给药方案取决于患者的诊断、癌症分期以及整体健康状况。常见不良反应可能包括疲劳、恶心、呕吐以及血细胞计数变化。出现任何潜在不良反应，请务必与您的医疗提供者讨论。Eleftha 150mg 注射剂应按照制造商的说明进行储存，通常在室温并避光保存。请始终咨询您的医生或药师，以获取关于用药及潜在风险的完整信息。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Strength |
其他品牌的 Trastuzumab 150 Mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
